Report lays out strategy to end “postcode prescribing”BMJ 2000; 320 doi: https://doi.org/10.1136/bmj.320.7241.1027/a (Published 15 April 2000) Cite this as: BMJ 2000;320:1027
- Jacqui Wise
Expensive drugs should not be available on the NHS until their clinical effectiveness and cost effectiveness have beenevaluated by the National Institute for Clinical Excellence (NICE), a new report concludes.
A working party report from the Royal College of Physicians, The Prescribing of Costly Medicines, says that once a newmedicine has fulfilled all the criteria for purchase by the NHS then it should become available everywhere. This should …